Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Five killed in Israeli air strikes on tents near Khan Younis, medics say - 2'Crammed into a cell with vermin at New Year'
- 3Best Augmented Simulation Ride: Which One Feels Generally Genuine?
- 4Bennu asteroid samples provide clues about solar system origins and 'space gum'
- 5Wisconsin archaeologists identify 16 ancient canoes in a prehistoric lake 'parking lot'
- The Most Encouraging New companies to Look Out For
- Pulsars to the extreme: Spinning dead stars found blasting radio signals from the 'edge of their magnetic reach'
- Colombia's military rescues 6 siblings who hid in the rainforest to escape from a rebel group
- Authorities Bust Camel Booze Smuggling Operation, Seize Nearly 2,000 Containers of Illegal Alcohol
- 1st human missions to Mars should hunt for signs of life, report says
- The Starbucks for Life game is back, along with your chance to win a 'Bearista' cold cup. Here's how to get your paws on one.
- Step by step instructions to Explore the Close to home Consequence of Cellular breakdown in the lungs
- Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
